Moderna partners with Takeda, Japanese government on additional 50 million COVID-19 vaccine dosesMarket Watch • 07/20/21
Moderna Partners with Takeda and the Government of Japan to Supply Additional 50 Million Doses of Moderna's COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022Business Wire • 07/20/21
Japan Health Ministry Supports Lowering Minimum Age For Moderna's COVID-19 Vaccine To 12 YearsBenzinga • 07/19/21
4 Large-Cap Healthcare Stocks You'll Want on Your Radar for the Second Half of 2021The Motley Fool • 07/18/21
This Nasdaq Vaccine Stock Just Got a Big Boost -- and Another Nasdaq Vaccine Stock Deserves the CreditThe Motley Fool • 07/16/21
MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500InvestorPlace • 07/16/21
Moderna gets the ultimate Wall Street validation: It's being added to the S&P 500CNN Business • 07/16/21
Moderna spikes 8% to record highs after it is selected to be added to S&P 500Business Insider • 07/16/21